LifeVantage (NASDAQ:LFVN) Shares Pass Below Two Hundred Day Moving Average of $6.42

Shares of LifeVantage Co. (NASDAQ:LFVNGet Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.42 and traded as low as $6.03. LifeVantage shares last traded at $6.05, with a volume of 42,786 shares.

LifeVantage Stock Performance

The firm’s 50-day simple moving average is $6.60 and its 200-day simple moving average is $6.42. The company has a market capitalization of $77.86 million, a price-to-earnings ratio of 26.30 and a beta of 0.78.

LifeVantage (NASDAQ:LFVNGet Free Report) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $51.62 million for the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%.

LifeVantage Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date was Thursday, February 29th. LifeVantage’s dividend payout ratio is 60.87%.

Hedge Funds Weigh In On LifeVantage

An institutional investor recently raised its position in LifeVantage stock. Ritholtz Wealth Management grew its position in LifeVantage Co. (NASDAQ:LFVNFree Report) by 23.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 25,027 shares of the company’s stock after purchasing an additional 4,756 shares during the period. Ritholtz Wealth Management owned about 0.20% of LifeVantage worth $150,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 35.32% of the company’s stock.

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Articles

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.